CCL2 and colorectal carcinoma: In a mouse model of transplantable colorectal carcinoma (CRC), it was found that fibroblasts expressing high levels of FAPα recruited myeloid cells via CCL2, which resulted in resistance to anti-PD-1 immune checkpoint therapy that was eliminated by targeting the FAPα.